Syquant Capital SAS’s SpringWorks Therapeutics SWTX Stock Holding History

Syquant Capital SAS’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-247,000	Closed	-$11.6M	–	24
2025 Q2	$11.6M	Buy	+247,000	New	+$11M	3.85%	7

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Syquant Capital SAS's SWTX Position: Q3 2025 in Review

Syquant Capital SAS sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 247,000 shares — an estimated $11.6M sold.

Syquant Capital SAS first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $11.6M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Syquant Capital SAS reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Syquant Capital SAS sold 247,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $11.6M.
Syquant Capital SAS first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Syquant Capital SAS's SpringWorks Therapeutics position peaked at $11.6M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Syquant Capital SAS's 13F filing for Q3 2025, filed 28 Oct 2025.